Info
Schedule 13D/G History
Ownership

Lawrence M. Blatt - Significant Ownership

Signature - Title: Lawrence M. Blatt, Ph.D. - Lawrence M. Blatt, Ph.D.
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Lawrence M. Blatt.

Significant Ownership of Lawrence M. Blatt

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ALGS	Aligos Therapeutics, Inc.	Common Stock, par value $0.0001 per share	3.2%	$1.45M		176K		Lawrence M. Blatt, Ph.D.	Mar 10, 2025

Showing 1 to 1 of 1 entries

Schedules 13D/G Reported by Lawrence M. Blatt:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed
ALGS	Aligos Therapeutics, Inc.	Common Stock, par value $0.0001 per share	3.2%		176K		$1.45M	Lawrence M. Blatt, Ph.D.	13D/A	3/10/2025	3/12/2025

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.